Depression during pregnancy

Magdalena Wójcik, Grzegorz Boreński, Przemysław Szabat, Julita Poleszak, Marta Szabat, Joanna Milanowska

Abstract


Introduction: Depression during pregnancy seems to be dominated by the postpartum depression. It is important to remember about this condition and its symptoms as they are easy to be mistaken with mood changes and other behavioural changes common during pregnancy. Although we know the risk factors for this condition, we still do not know its complex etiology. Moreover, there is also not enough information about the treatment.
The aim of the study: The purpose of this systemic review was to collect and analyse causes and possibilities of treatment depression during pregnancy.
Material and method: Standard criteria were used to review the literature data. The search of articles in the PubMed and Google Scholar database was carried out using the following keywords: depression, treatment, pregnancy.
Description of the state of knowledge: Currently the most common treatment for pregnant women suffering from depression are selective serotonin reuptake inhibitors, especially citalopram, escitalopram, paroxetine, fluoxetine, fluvoxamine and sertraline. However, their potential side effects affecting the fetus is a controversial issue. The results of many studies are not consistent.
Summary: It is still not known how to treat depression during pregnancy properly. Psychotherapy, considered as a basic way of treatment, is always recommended. However, the usage of selective serotonin reuptake inhibitors is still open to debate.

Keywords


depression; pregnancy; treatment

Full Text:

PDF

References


Howdeshell KL, Ornoy A. Depression and Its Treatment During Pregnancy: Overview and Highlights. Birth defects research. 2017109(12):877-878.

Charlton RA, Jordan S, Pierini A, Garne E, Neville AJ, Hansen AV,et al. Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population-based study in six European regions. BJOG. 2015 122(7):1010-20.

Rai D, Lee BK, Dalman C, Newschaffer C, Lewis G, Magnusson C. Antidepressants during pregnancy and autism in offspring: population based cohort study. BMJ (Clinical research ed.). 2017358:j2811.

Ornoy A, Koren G. Selective serotonin reuptake inhibitors during pregnancy: do we have now more definite answers related to prenatal exposure?. Birth defects research. 2017109(12):898-908.

Thompson BL, Levitt P, Stanwood GD. Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nature reviews. Neuroscience. 200910(4): 303-12.

Homberg JR, Schubert D, Gaspar P. New perspectives on the neurodevelopmental effects of SSRIs. Trends Pharmacol Sci. 2010 31:60-5.

Lauder JM, Wallace JA, Krebs H. Roles for serotonin in neuroembryogenesis. AdvExp Med Biol. 1981 133:477-506.

Diagnostic and Statistical Manual of Mental Disorders(DSM–5), American Psychiatric Association, 2013.

Yang L, Zhao Y, Wang Y, Liu L, Zhang X, Li B, et al. The Effects of Psychological Stress on Depression. Current neuropharmacology. 2015 13(4):494-504.

Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, et al. Mood Disorders in the Medically Ill: Scientific Review and Recommendations. Biol Psychiatry. 2005 1;58(3):175-89.

Berk M, Williams LJ, Jacka FN, O'Neil A, Pasco JA, Moylan S, et al. So depression is an inflammatory disease, but where does the inflammation come from?. BMC medicine. 2013 11:200.

Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM, et al. Neurobiology of Depression. Neuron. 2002 28;34(1):13-25.

Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 2008 31(9):464-8.

Bissette G, Klimek V, Pan J, Stockmeier C, Ordway G. Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology. 2003 28(7):1328-35.

Keck ME, Ohl F, Holsboer F, Müller MB. Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders. Neurosci Biobehav Rev. 2005 29(4-5):867-89.

Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006 7(2):137-51.

Hashimoto K. The role of glutamate on the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 2011 35(7):1558-68.

Bosch OJ. Look behind the eyes - vasopressin rules the day. The Journal of physiology. 2017 595(11):3245.

Lener MS, Niciu MJ, Ballard ED, Park M, Park LT, Nugent AC, et al. Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine. Biological psychiatry. 2016 81(10):886-897.

Fee C, Banasr M, Sibille E. Somatostatin-Positive Gamma-Aminobutyric Acid Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives. Biological psychiatry. 2017 82(8):549-559.

Blier P, El Mansari M. Serotonin and beyond: therapeutics for major depression. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 2013 368(1615):20120536.

Leff-Gelman P, Mancilla-Herrera I, Flores-Ramos M, Cruz-Fuentes C, Reyes-Grajeda JP, García-Cuétara M, et al. The Immune System and the Role of Inflammation in Perinatal Depression. Neuroscience bulletin. 2016 32(4):398-420.

Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord. 2012 139(3):230-9.

Koo JW, Duman RS. Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression. Current opinion in investigational drugs (London, England: 2000). 2009 10(7):664-71.

Koo JW, Duman RS. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proceedings of the National Academy of Sciences of the United States of America. 2008 105(2):751-6.

Kaster MP, Gadotti VM, Calixto JB, Santos AR, Rodrigues AL. Depressive-like behavior induced by tumor necrosis factor-α in mice. Neuropharmacology. 2012 62(1):419-426.

Veenstra van Nieuwenhoven AL, Heineman MJ, Faas MM. The immunology of successful pregnancy. Hum Reprod Update. 2003 9(4):347-57.

Trowsdale J, Betz AG. Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol. 2006 7(3):241-6.

Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. American journal of reproductive immunology (New York, N.Y. : 1989). 2010 63(6):425-33.

Gelman PL, Flores-Ramos M, López-Martínez M, Fuentes CC, Grajeda JP. Hypothalamic-pituitary-adrenal axis function during perinatal depression. Neuroscience bulletin. 2015 31(3):338-50.

Rai S, Pathak A, Sharma I. Postpartum psychiatric disorders: Early diagnosis and management. Indian journal of psychiatry. 2015 57(2):216-21.

Henshaw C. Mood disturbance in the early puerperium: A review. Arch WomensMent Health. 2003 6(2):33–42.

Langan R, Goodbred AJ. Identification and management of peripartum depression. Am Fam Physician. 2016 93(10):852-858.

Bunevicius R, Kusminskas L, Mickuviene N, Bunevicius A, Pedersen CA, Pop VJ. Depressive disorder and thyroid axis functioning during pregnancy. The World Journal of Biological Psychiatry. 2009 10(4):324-329.

Harris B, Othman S, Davies JA, Weppner GJ, Richards CJ, Newcombe RG, et al. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ (Clinical research ed.). 1992 305(6846):152-6.

Doornbos B, Dijck-Brouwer DJ, Kema IP, Tanke MA, van Goor SA, Muskiet FA, et al. The development of peripartum depressive symptoms is associated with gene polymorphisms of MAOA, 5-HTT and COMT. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2009

(7):1250-1254.

American College of Obstetricinas and Gynecologists. ACOG Committee Opinion No. 343: psychosocial risk factors: perinatal screening and intervention. Obstet Gynecol. 2006 108(2):469-77.

Lancaster CA, Gold KJ, Flynn HA, Yoo H, Marcus SM, Davis MM. Risk factors for depressive symptoms during pregnancy: a systematic review. American journal of obstetrics and gynecology. 2010 202(1):5-14.

Evans J, Heron J, Francomb H, Oke S, Golding J. Cohort study of depressed mood during pregnancy and after childbirth. BMJ (Clinical research ed.). 2001 323(7307):257-60.

Yonkers KA, Smith MV, Gotman N, Belanger K. Typical somatic symptoms of pregnancy and their impact on a diagnosis of major depressive disorder. General hospital psychiatry. 2009 31(4):327-33.

Mikšić Š, Miškulin M, Juranić B, Rakošec Ž, Včev A, Degmečić D. Depression and suicidality during pregnancy. PsychiatriaDanubina. 2018 30(1):85-90.

Dmitrovic BK, Dugalić MG, Balkoski GN, Dmitrovic A, Soldatovic I. Frequency of perinatal depression in Serbia and associated risk factors. International Journal of Social Psychiatry. 2014 60(6):528-532.

Vesga-López O, Blanco C, Keyes K, Olfson M, Grant BF, Hasin DS. Psychiatric disorders in pregnant and postpartum women in the United States. Archives of general psychiatry. 2008 65(7):805-15.

Bergink V, Kooistra L, Lambregtse-van den Berg MP, Wijnen H, Bunevicius R, van Baar A, et al. Validation of the Edinburgh Depression Scale during pregnancy. Journal of psychosomatic research. 2011 70(4):385-389.

Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Archives of general psychiatry. 2010 67(10):1012-24.

Diego MA, Field T, Hernandez-Reif M, Schanberg S, Kuhn C, Gonzalez-Quintero VH. Prenatal depression restricts fetal growth. Early human development. 2008 85(1):65-70.

Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I. Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics. 2014 133(5):1241-8.

Mulder EJ, Anderson GM, Kema IP, De Bildt A, Van Lang ND, Den Boer JA, et al. Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates.J Am Acad Child Adolesc Psychiatry. 2004

(4):491–499.

Andrade C. Antidepressant Exposure During Pregnancy and Risk of Autism in the Offspring, 1: Meta-Review of Meta-Analyses. J Clin Psychiatry. 2017 78(8):1047-1051.

Wogelius P, Nørgaard M, Gislum M, Pedersen L, Munk E, Mortensen PB, et al. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology. 2006 17(6):701-704.

Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, et al. Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors. Clinical therapeutics. 2007 29(5):918-926.

Ban L, Tata LJ, West J, Fiaschi L, Gibson JE. Live and non-live pregnancy outcomes among women with depression and anxiety: a population-based study. PloS one. 2012 7(8):e43462.

Huybrechts KF, Bateman BT, Palmsten K, Desai RJ, Patorno E, Gopalakrishnan C, et al. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA. 2015 313(21):2142-51.

Nörby U, Forsberg L, Wide K, Sjörs G, Winbladh B, Källén K. Neonatal morbidity after maternal use of antidepressant drugs during pregnancy. Pediatrics. 2016 138(5):e20160181.

Yonkers KA, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. General hospital psychiatry. 2009 31(5):403-13.

Spinelli M, Endicott J. Controlled clinical trial of interpersonal psychotherapy versus parenting education program for depressed pregnant women. Am J Psychiatry. 2003 160:555–562.




DOI: http://dx.doi.org/10.5281/zenodo.2604908

Refbacks

  • There are currently no refbacks.




Copyright (c) 2019 © The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Journal of Education, Health and Sport formerly Journal of Health Sciences

Declaration on the original version.

Editors indicates that the main version of the magazine is to issue a "electronic".

The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.

1223 Journal of Education, Health and Sport eISSN 2391-8306 7

ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

Archives 2011 - 2014

PBN 2011 - 2014

https://pbn.nauka.gov.pl/sedno-webapp/search?search&searchCategory=WORK&filter.inJournal=36616

POL-index 2011 - 2014

https://pbn.nauka.gov.pl/polindex-webapp/browse/journal/journal-32a319c5-a850-4f44-ba70-1418a6087655

BASE 2011 - 2014

https://www.base-search.net/Search/Results?lookfor=Journal+of+Health+Sciences+%28Radom%29&type=all&oaboost=1&ling=1&name=&thes=&refid=dcrespl&newsearch=1

http://elibrary.ru/contents.asp?titleid=37467

http://journal.rsw.edu.pl/index.php/JHS/issue/archive

Indexed in Bases, Bazy indeksacyjne: ERIH Plus, Worldcat, PBN/POL-Index, ICI Journals Master List, Directory of Open Access Journals (DOAJ), ZBD, Ulrich's periodicals, Google Scholar, Polska Bibliografia Lekarska

US NLM = 101679844

101679844 - NLM Catalog Result - NCBI

https://www.ncbi.nlm.nih.gov/nlmcatalog/101679844

Find a library that holds this journal: http://worldcat.org/issn/23918306

Journal Language(s): English 

PBN Poland

https://pbn.nauka.gov.pl/sedno-webapp/journals/49068

POL-index

https://pbn.nauka.gov.pl/polindex-webapp/browse/journal/journal-c39c8169-88d2-45db-9e7f-d948ce9981c4

BASE

https://www.base-search.net/Search/Results?join=AND&bool0[]=AND&lookfor0[]=2391-8306&type0[]=all&page=11&l=pl&oaboost=1&refid=dcpagepl

Redaction, Publisher and Editorial Office

Instytut Kultury Fizycznej Uniwersytet Kazimierza Wielkiego w Bydgoszczy, Institute of Physical Education Kazimierz Wielki University in Bydgoszcz, Poland 85-091 Bydgoszcz ul. Sportowa 2  www.ukw.edu.pl Copyright by Instytut Kultury Fizycznej UKW w Bydgoszczy http://ojs.ukw.edu.pl/index.php/johs  Open Access ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

The journal has been approved for inclusion in ERIH PLUS.

The ERIH PLUS listing of the journal is available at https://dbh.nsd.uib.no/publiseringskanaler/erihplus/periodical/info?id=485984

SIC Science citation index (calculated on the basis of TCI and Page Rank) 0

Russian Impact factor 0.16

Indexed in Index Copernicus Journals Master List.

http://journals.indexcopernicus.com/Journal+of+Education+Health+and+Sport,p24782242,3.html

ICV 2018 = 95.95 ICV 2017 = 91.30 ICV 2016 = 84.69 ICV 2015 = 93.34 ICV 2014 = 89.51 Standardized Value: 8.27 ICV 2013: 7.32 ICV 2012: 6.41 ICV 20115.48

The InfoBase Index IBI Factor for the year 2015 is 3.56 in InfoBase Index.com.

Website: www.infobaseindex.com

Universal Impact Factor 1.78 for year 2012. (http://www.uifactor.org/AppliedJournals.aspx)

Indexed in Polish Scholarly Bibliography (PBN) (PBN Polska Bibliografia Naukowa) (https://pbn.nauka.gov.pl/journals/36616)

is a portal of the Polish Ministry of Science and Higher Education, collecting information on publications of Polish scientists and on Polish and foreign scholarly journals. Polish Scholarly Bibliograhpy is a part of POL-on - System of Information on Higher Education. It is operated by the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw.

Indexed in Russian Sciences Index Российский индекс научного цитирования (РИНЦ) http://elibrary.ru/contents.asp?titleid=37467

Indexed in Arianta Polish scientific and professional electronic journals Aneta Drabek i Arkadiusz Pulikowski

(http://www1.bg.us.edu.pl/bazy/czasopisma/czasop_full.asp?id=3595)